IL110888A - Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound - Google Patents
Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compoundInfo
- Publication number
- IL110888A IL110888A IL11088894A IL11088894A IL110888A IL 110888 A IL110888 A IL 110888A IL 11088894 A IL11088894 A IL 11088894A IL 11088894 A IL11088894 A IL 11088894A IL 110888 A IL110888 A IL 110888A
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- pharmaceutical compositions
- liver diseases
- vasodilating compound
- vasodilating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Electrotherapy Devices (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPM110493 | 1993-09-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL110888A0 IL110888A0 (en) | 1994-11-28 |
IL110888A true IL110888A (en) | 1999-07-14 |
Family
ID=3777184
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11088894A IL110888A (en) | 1993-09-08 | 1994-09-08 | Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0717625B1 (de) |
JP (1) | JP3842815B2 (de) |
KR (1) | KR100350156B1 (de) |
CN (1) | CN1115151C (de) |
AT (1) | ATE218869T1 (de) |
CA (1) | CA2170289C (de) |
DE (1) | DE69430807T2 (de) |
FI (1) | FI961029A0 (de) |
HK (1) | HK1003422A1 (de) |
IL (1) | IL110888A (de) |
NO (1) | NO960866L (de) |
NZ (1) | NZ273242A (de) |
SG (1) | SG49645A1 (de) |
WO (1) | WO1995007080A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5854233A (en) * | 1993-09-08 | 1998-12-29 | Pharmacy And Therapeutic Advisory Consultancy Ltd. | Method of treating liver disease and like indications with vasodilating agents |
US6174917B1 (en) | 1993-09-08 | 2001-01-16 | Pharmacy And Therapeutic Advisory Consultancy Ltd. | Method of treating liver disease and like indications with vasodilating agents |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992004008A1 (en) * | 1990-09-07 | 1992-03-19 | Universidad De Alicante | Composition for treating ocular pain |
ZA923474B (en) * | 1991-05-20 | 1993-01-27 | Marion Merrell Dow Inc | Diltiazem formulation |
-
1994
- 1994-09-05 SG SG1996002734A patent/SG49645A1/en unknown
- 1994-09-05 KR KR1019960701141A patent/KR100350156B1/ko not_active IP Right Cessation
- 1994-09-05 CN CN94193320A patent/CN1115151C/zh not_active Expired - Fee Related
- 1994-09-05 JP JP50835595A patent/JP3842815B2/ja not_active Expired - Fee Related
- 1994-09-05 CA CA002170289A patent/CA2170289C/en not_active Expired - Fee Related
- 1994-09-05 DE DE69430807T patent/DE69430807T2/de not_active Expired - Fee Related
- 1994-09-05 EP EP94926719A patent/EP0717625B1/de not_active Expired - Lifetime
- 1994-09-05 NZ NZ273242A patent/NZ273242A/en unknown
- 1994-09-05 AT AT94926719T patent/ATE218869T1/de not_active IP Right Cessation
- 1994-09-05 WO PCT/AU1994/000525 patent/WO1995007080A1/en active IP Right Grant
- 1994-09-08 IL IL11088894A patent/IL110888A/xx not_active IP Right Cessation
-
1996
- 1996-03-04 NO NO960866A patent/NO960866L/no not_active Application Discontinuation
- 1996-03-06 FI FI961029A patent/FI961029A0/fi unknown
-
1998
- 1998-03-24 HK HK98102526A patent/HK1003422A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ273242A (en) | 2001-04-27 |
HK1003422A1 (en) | 1998-10-30 |
ATE218869T1 (de) | 2002-06-15 |
CN1130874A (zh) | 1996-09-11 |
IL110888A0 (en) | 1994-11-28 |
CA2170289A1 (en) | 1995-03-16 |
FI961029A (fi) | 1996-03-06 |
JPH09502188A (ja) | 1997-03-04 |
EP0717625A1 (de) | 1996-06-26 |
DE69430807T2 (de) | 2002-12-19 |
CN1115151C (zh) | 2003-07-23 |
CA2170289C (en) | 2001-05-08 |
SG49645A1 (en) | 1999-10-19 |
WO1995007080A1 (en) | 1995-03-16 |
FI961029A0 (fi) | 1996-03-06 |
NO960866D0 (no) | 1996-03-04 |
NO960866L (no) | 1996-03-04 |
DE69430807D1 (de) | 2002-07-18 |
EP0717625A4 (de) | 1997-12-29 |
JP3842815B2 (ja) | 2006-11-08 |
EP0717625B1 (de) | 2002-06-12 |
KR100350156B1 (ko) | 2003-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05006940A (es) | Formulaciones terapeuticas para el tratamiento de enfermedades relacionadas con beta - amiloide. | |
DE69815122D1 (de) | Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen | |
ATE515265T1 (de) | Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen | |
SE8903914D0 (sv) | Oral composition for the treatment of inflammatory bowel diseases | |
EE9900428A (et) | Köhavastased ravimkoostised | |
ES2160643T3 (es) | Composiciones que contienen g-csf y proteina de union al tnf. | |
HU229598B1 (en) | Preparations for the application of anti-inflammatory agents | |
HUP0202525A2 (hu) | Mofetil mikofenolát és PEG-IFN-alfa együttes alkalmazása, valamint az azokat tartalmazó gyógyszerkészítmények és kit | |
ATE458471T1 (de) | Formulierungen mit povidon-iod zur behandlung von wunden | |
Newell | Pharmacokinetically guided dose escalation in phase I clinical trials: Commentary and proposed guidelines. | |
IL110888A (en) | Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound | |
AU3401093A (en) | Therapeutic agent for threatened abortion | |
BG103905A (en) | New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine | |
FR2437832A1 (fr) | Medicament a base de p-tolyl diiodomethylsulfone utile notamment pour le traitement des infections cutanees provoquees par les levures et les champignons | |
AR025549A1 (es) | Mofetil micofelonato en asociacion con peg-ifn-alfa | |
ES2101311T3 (es) | Utilizacion de un dispositivo transdermico que contiene (e)-2-(p-fluorofenetil)-3-fluoroalilamina y su uso para el tratamiento de la enfermedad de alzheimer. | |
HU9201295D0 (en) | Medical preparations for treating cryptosporidiosys | |
HU9802896D0 (en) | Optically active piperidinoalkyl-4h-1,2,4-oxadiazine derivative, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
IT1142260B (it) | L-alanina come agente farmaceutico impiegato per la cura di cerebropatie vascolari e relative formulazioni | |
UA7971C2 (uk) | Спосіб профілактики післяпологових захворювань корів | |
IT1275987B1 (it) | Composizione farmaceutica attiva nella cura di affezioni dermatologiche | |
ECSP003616A (es) | Micofenolato mofetil en asociacion con peg-ifn-alfa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |